Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023-02-08 | PMID 35737946
Boucau Julie, Uddin Rockib, Marino Caitlin and 18 more
